Abdominal symptoms during Sjogren’s syndrome: a pilot study
Open Access
- 19 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Advances in Rheumatology
- Vol. 61 (1), 1-8
- https://doi.org/10.1186/s42358-021-00164-w
Abstract
Abdominal symptoms in patients with primary Sjögren syndrome (pSS) are poorly documented. The objective of the study was to describe the abdominal symptoms of patients with pSS and to assess their association with characteristics of the disease. One hundred and fifty patients with pSS were evaluated using a composite global symptom score for abdominal symptoms and their severity. Data concerning the clinical and biological characteristics of pSS and abdominal disorders were also collected. Of the patients with pSS, 95% suffered from abdominal symptoms (median global symptom score 7.5 ± 5.5 points out of 30). More than half of the patients experienced abdominal tension (68%), upper abdominal pain (54%), abdominal discomfort (58%) and/or constipation (54%). Regarding the pSS activity, in relation to European League Against Rheumatism (EULAR) Sjögren syndrome disease activity index score items, general and central nervous system involvement wereassociated with a high global symptom score. The EULAR Sjogren Syndrome Patient Reported Index (ESSPRI) symptom score was positively correlated with the global symptom score (p < 0.01). Multivariate analysis showed a significant association between a high global symptom score and SSA seronegativity, gastroparesis, and ESSPRI score (p < 0.01 for each). The majority of patients with pSS suffered abdominal symptoms. There is currently no therapeutic recommendation because of the lack of information on the underlying pathophysiological mechanisms. NCT03157011. Date of registration: July 17, 2017.Keywords
This publication has 31 references indexed in Scilit:
- Delayed gastric emptying determined using the 13C–octanoic acid breath test in patients with systemic sclerosisArthritis & Rheumatism, 2012
- Gastrointestinal and Hepatic Manifestations of Sjogren SyndromeJournal of Clinical Gastroenterology, 2012
- Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndromeArthritis & Rheumatism, 2011
- Impaired Gastric Emptying in Primary Sjögren’s SyndromeThe Journal of Rheumatology, 2010
- Small intestinal bacterial overgrowth in systemic sclerosisRheumatology, 2009
- Bowel symptoms in patients with primary Sjögren's syndromeScandinavian Journal of Rheumatology, 2007
- Natural Course of Functional Dyspepsia After Helicobacter pyloriEradication: A Seven-Year SurveyDigestive Diseases and Sciences, 2005
- Neutralization of Muscarinic Receptor Autoantibodies by Intravenous Immunoglobulin in Sjögren SyndromeHuman Immunology, 2005
- Efficacy of Mesalazine in the Treatment of Symptomatic Diverticular DiseaseDigestive Diseases and Sciences, 2005
- Guidelines of the French Society of Digestive Endoscopy: Total Colonoscopy IndicationsEndoscopy, 2000